A Clinical Study on a Polyherbal Unani Formulation in the treatment of Chronic Gout (Hyperuricemia).
Phase 2
Completed
- Conditions
- Health Condition 1: - Health Condition 2: E798- Other disorders of purine and pyrimidine metabolism
- Registration Number
- CTRI/2022/01/039544
- Lead Sponsor
- Central Council for Research in Unani Medicine New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Clinically/Radiologically diagnosed patients of Chronic Gout with Sr. Uric Acid Level > 7.2 mg/dL.
1. Patients with Joint Pain.
2. Patients with morning stiffness > 30 minutes.
3. Patients with joint swelling of the affected joint(s).
4. Patients with muscular weakness of the joint(s).
5. Patients with restricted movement of the joint(s).
Exclusion Criteria
1. Any other disease or syndrome except Niqris.
2. Pregnant and Lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relief in signs and symptoms of Chronic GoutTimepoint: 28 Days
- Secondary Outcome Measures
Name Time Method Haematological, Radiological and Bio-Chemical assessment.Timepoint: 28 Days